About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Serum Collection Study for Assay Development | Clinical Trials | Clareo Health

RECRUITINGPhase 1

Serum Collection Study for Assay Development

A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation

NCT07205289•GPN Vaccines

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Pneumococcal Disease, InvasivePneumococcal Disease

Interventions

Gamma-PN

Locations

1

Australia

Locations (1)

University of Adelaide Clinical Research Facility

Adelaide, South Australia, Australia

Key Dates

Start Date

October 1, 2025

Primary Completion Date

January 1, 2026

Completion Date

June 1, 2026

Last Updated

October 3, 2025

Related Studies

RECRUITINGPhase 4

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

NCT06731374

Pneumococcal DiseasePneumococcal Carriage

RECRUITINGPhase 3

A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

NCT06044077

Pneumococcal Disease

Active Not RecruitingPhase 2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

NCT06790290

Pneumococcal Disease, Invasive

COMPLETEDPhase 3

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)

NCT05569954

Pneumococcal Disease

COMPLETEDPhase 1

A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults

NCT07019909

Pneumococcal Disease

COMPLETEDPhase 3

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

NCT04875533

Pneumococcal Disease

View all related studies

Contacts

Nerissa Lakhan, PhD

CONTACT

+61-432 161 783 nerissa@gpnvaccines.com

Paul E Rolan, MD

CONTACT

+61-405 670 420 paul@gpnvaccines.com

Sponsors

Lead Sponsor

GPN Vaccines

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2025Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions